On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...